Christine Blank

FDA is permitting marketing of the first medical device that uses artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy.

FDA approved a new indication for Exparel Bupivacaine Liposome injectable suspension (Exparel, Pacira) for use as a nerve block to produce post-surgical regional analgesia following shoulder surgery in adults.

FDA okayed the marketing of a new continuous glucose monitoring system for diabetics-the first to be used as part of an integrated system with other compatible medical devices and electronic interfaces.

As FDA considers new guidelines on pharmaceutical product marketing, a new study found that pharma makers may not be following current FDA ad regulations.

Over the past few months, several new diabetes treatments have been approved by FDA. Here are the top 3 novel drugs for diabetes.

A new FDA-approved drug offers new hope for patients with multidrug-resistant HIV-1 infection.

FDA should provide better education about biosimilar drugs on the agency’s web site dedicated to biosimilars, a patient advocacy group said.

FDA recently approved 3 major drugs to treat lung cancer, prostate cancer, and cystic fibrosis. Here are the top 3 new drug approvals.

A pharmacist organization is among the supporters of a new Medicare Part D proposal, which calls for a 7-day supply limit on opioid prescriptions.

Due to the increased use of illicit fentanyl mixed with heroin and used in counterfeit prescription drugs, the DEA placed all illicit fentanyl analogues not already regulated by the Controlled Substances Act into Schedule I.

FDA approved Allergan's supplemental New Drug Application (sNDA) to expand the approved use of ceftazidime and avibactam (Avycaz) to include 2 types of pneumonia.

FDA is adding a Boxed Warning, its most prominent warning, on a liver disease medicine.

A pharmaceutical formulation of purified cannabidiol, a cannabinoid without euphoric side effects, is expected to launch in the second half of this year.

A patient advocacy group is criticizing the hefty price tag of a new treatment for blindness.

Patients with systemic lupus erythematosus often self-manage their corticosteroid medication without the consent of their healthcare providers, according to a recent multicountry survey.

FDA is taking its toughest stance yet on opioid-containing cough and cold medications for children.

FDA approved the first drug to treat certain patients with metastatic breast cancer who have a “BRCA” gene mutation.

While hospitals continue to face IV saline shortages after two hurricanes significantly damaged infrastructure in Puerto Rico, the situation should improve early this year.

A new study reveals interesting findings about improving the health of pediatric asthma patients and integrated care programs.

While breastfeeding has been thought to decrease children’s risk of developing allergies and asthma, a new study counters that belief.

Allergist Bradley Chipps, MD, shares research on how to fine-tune asthma management strategies.

A Canadian study reveals how clinicians may be able to identify whether asthma will develop in patients as young as age one.

The National Association of Boards of Pharmacy has developed a platform for sharing prescription monitoring programs